The value of routine monitoring of mycophenolic acid plasma levels after clinical heart transplantation.
Hesse
C J
CJ
Department of Internal Medicine and Thorax Center, Erasmus University, and University Hospital Rotterdam-Dijkzigt, Rotterdam, The Netherlands.
Vantrimpont
P
P
van Riemsdijk-van Overbeeke
I C
IC
van Gelder
T
T
Balk
A H
AH
Weimar
W
W
D000208:Acute Disease; D001706:Biopsy; D016572:Cyclosporine / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D016903:Drug Monitoring; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000097:blood; D016027:Heart Transplantation / Q000276:immunology / Q000473:pathology / Q000502:physiology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000493:pharmacokinetics* / Q000627:therapeutic use; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000097:blood* / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D016559:Tacrolimus / Q000627:therapeutic use; D013997:Time Factors
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D009173:Mycophenolic Acid; D016559:Tacrolimus